Nachrichten zur Bristol-Myers Squibb Co Aktie

European advisory group backs Bristol Myers Opdivo + Yervoy as first-line treatment in lung cancer

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Squibb Cuts Deal, Delaying Threat to Top-Selling Revlimid

Bristol-Myers Squibb has come to terms on an agreement to delay entry of a generic version of its multiple myeloma…

Bristol Myers O+Y shows long-term survival benefit in kidney cancer

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol Myers Squibb (BMY) Stock Moves -0.13%: What You Should Know

In the latest trading session, Bristol Myers Squibb (BMY) closed at $59.45, marking a -0.13% move from the previous day....…

The Bristol-Myers CVR Is Worth $7.83

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

EMA accepts Bristol Myers application for O+Y for first-line treatment of type of lung cancer

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Obsidian Therapeutics Announces Bristol Myers Squibb Opt-In of cytoDRiVE™ Cell Therapy Candidate

CAMBRIDGE, Mass. , Sept. 15, 2020 /PRNewswire/ --  …

Top Research Reports for Facebook, McDonalds & Bristol-Myers

Top Research Reports for Facebook, McDonalds & Bristol-Myers...…

Daily Dividend Report: AbbVie, Bristol Myers Squibb, Colgate-Palmolive, American Tower, Cerner

Daily Dividend Report: AbbVie, Bristol Myers Squibb, Colgate-Palmolive, American Tower, Cerner...…

Bristol Myers Squibb (BMY) Stock Moves -1.34%: What You Should Know

Bristol Myers Squibb (BMY) closed at $58.29 in the latest trading session, marking a -1.34% move from the prior day....…

Bristol Myers Squibb Declares Fresh Dividend; Yield Is 3.1%

The reliable dividend payer will probably hike its next distribution....…

Bristol-Myers Squibb Company (BMY) Management Presents at Citi 15th Annual Biopharma Conference (Transcript)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Is Bristol Myers (BMY) Down 2.3% Since Last Earnings Report?

Bristol Myers (BMY) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…

Bristol Myers Squibb (BMY) Stock Moves -0.17%: What You Should Know

Bristol Myers Squibb (BMY) closed the most recent trading day at $59.95, moving -0.17% from the previous trading session....…

Bristol Myers Gets FDA Approval for Oral AML Therapy Onureg

Bristol Myers (BMY) Onureg becomes the first and only FDA-approved continued AML therapy for patients in remission....…

Bristol Myers Squibb Wins FDA Approval for Leukemia Drug

Onureg is aimed at treating a particularly aggressive form of the disease....…

The Week Ahead In Biotech: Bristol-Myers Squibb FDA Decision, Adcom Review For Glaxo, Amarin Vascepa Hearing

Biotech stocks went about a consolidation move in the week ended Aug. 28 amid thin news flow. Barring updates on coronavirus…

The Week Ahead In Biotech (Aug. 30- Sept. 5): Bristol-Myers Squibb FDA Decision, Adcom Review For Glaxo, Amarin Vascepa Hearing

Biotech stocks went about a consolidation move in the week ended Aug. 28 amid thin news flow. Barring updates on coronavirus…

Bristol-Myers Squibb: Too Cheap To Ignore

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol Myers to Buy Forbius to Boost Immunotherapy Pipeline

Bristol Myers (BMY) enters into an agreement to acquire privately-held Forbius in a bid to boost its pipeline of immunotherapies....…

Bristol Myers Squibb to acquire protein engineer Forbius

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BRISTOL MYERS SQUIBB CO: 8-K Report

CURRENT REPORT...…

Bristol Myers & Dragonfly Team Up for Immunotherapy Program

Bristol Myers (BMY) collaborates with Dragonfly Therapeutics, Inc. for its experimental immunotherapy program....…

Bristol Myers Squibb nabs rights to cancer candidate from Dragonfly Therapeutics

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Squibb: Celgene Effects Materializing

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol Myers Seeks to Diversify Trials With $300 Million Pledge

Bristol Myers Seeks to Diversify Trials With $300 Million Pledge...…

Bristol Myers Squibb Pledges $300 Million To Address Racial Inequality In Healthcare

The U.S. drugmaker said on Wednesday that it will invest $300 million over the next five years to tackle racial…

Bristol-Myers Squibb: A Cash Flowing Dividend Opportunity

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol Myers Squibb - Amazing Earnings, Rapid Debt Paydown

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Squibb (BMY) Q2 2020 Earnings Call Transcript

BMY earnings call for the period ending June 30, 2020....…

Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio on Q2 2020 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol Myers Squibb (BMY) Q2 Earnings and Revenues Top Estimates

Bristol Myers (BMY) delivered earnings and revenue surprises of 11.64% and 0.44%, respectively, for the quarter ended June 2020. Do…

Jim Cramer Says Bristol-Myers Stock Is Huge Buying Opportunity

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Squibb Boosts Outlook, Now That Patients Are Coming Back

The Thursday morning announcement followed the previous night’s good news of a patent victory for a big-selling heart drug it…

Bristol-Myers Squibb Company 2020 Q2 - Results - Earnings Call Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Mid-Morning Market Update: Markets Edge Higher; Bristol-Myers Squibb Earnings Top Estimates

Following the market opening Thursday, the Dow traded up 0.20% to 27256.88 while the NASDAQ rose 0.09% to 11,008.62. The…

Bristol-Myers (BMY) Q2 Earnings Beat, 2020 Earnings View Up

Bristol-Myers (BMY) beats on earnings and sales in the second quarter on the strength of Revlimid and Eliquis....…

Bristol Myers posts strong revenue growth of 62% driven by Celgene Acquisition

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

US-Pharmakonzern Bristol-Myers profitiert weiter von Celgene-Übernahme

NEW YORK (dpa-AFX) - Die Übernahme des Biopharmaspezialisten Celgene beschert dem US-Pharmakonzern Bristol-Myers Squibb (BMS) weiterhin hohes Wachstum. Der Konzern…

US-Pharmakonzern Bristol-Myers profitiert weiter von Celgene-Übernahme

NEW YORK (dpa-AFX) - Die Übernahme des Biopharmaspezialisten Celgene beschert dem US-Pharmakonzern Bristol-Myers Squibb (BMS) weiterhin…

BRISTOL MYERS SQUIBB CO: 8-K Report

8-K...…

Bristol Myers lifts annual profit view on hopes of pickup in patient visits

Bristol Myers Squibb Co raised its annual profit forecast on Thursday on hopes of a recovery in sales of…

The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) read more...…

Bristol-Myers Slips To Loss In Q2, But Results Top Estimates

Biopharmaceutical company Bristol-Myers Squibb Co. on Thursday reported a loss for the second quarter, compared to a profit last year,…

Bristol-Myers Squibbs stock is up on better-than-expected earnings

Shares of Bristol-Myers Squibb gained 4.2% in premarket trading on Thursday on better-than-expected earnings and a positive patent ruling…

Bristol Myers lifts annual profit view on hopes of pickup in patient visits to doctors

Bristol Myers Squibb Co raised its annual profit forecast on Thursday on hopes of a recovery in demand for…

Bristol Myers Squibb EPS beats by $0.16, beats on revenue

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ABIO To Start Phase 2 COVID-19 Trial In Q4, ACIU On Track, BCLI Expects ALS Trial Data In Nov.

Todays Daily Dose brings you news about ARCA biopharmas progress in its COVID-19 drug candidate, AC Immune upcoming milestones, BrainStorm…

Bristol-Myers, Pfizer stocks rise on blood-thinner patent win

Bristol-Myers Squibb Co. shares rallied in the extended session Wednesday after a federal judge ruled for it and Pfizer…

Bristol Myers Squibb Q2 2020 Earnings Preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…